Light-Activated Materials for Bioscaffold Fabrication and Controlled Drug Release Applications (LAMBDA)
Description of the granted funding
Photoresponsive systems for controlled drug release, extracellular matrix fabrication for tissue engineering emerged in the recent years due to their fine spatiotemporal control and non-invasiveness. Yet, most of them require phototoxic blue/UV light with poor tissue penetration. This issue will be overcome via triplet-triplet annihilation upconversion process that enables in situ blue/UV light generation upon safe red light-excitation of greater penetration depth. Thus, the process will allow to perform phototriggered drug release deeper in tissue with less phototoxicity. The similar issue in tissue engineering will be addressed by using a two-component system (containing red light-absorbing sensitizer and co-initiator) capable to create radicals upon safe red light-excitation. Hence, the red light will initiate free radical polymerization of an injectable polymer-cells suspension to form cell-laden hydrogel in situ deeper in tissue in minimally invasive and well controlled manner.
Show moreStarting year
2023
End year
2027
Granted funding
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Other information
Funding decision number
354792
Fields of science
Chemical sciences
Research fields
Fysikaalinen kemia
Identified topics
chemicals, toxicity